Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	n.A.	-7.03	n.A.
Graham Fair Price	n.A.	1.07	n.A.
PEG	inf	0.00	< 0.005
Price/Book	100.00	2.55	0.00
Price/Cash Flow	55.29	-6.72	-15.02
Prices/Earnings	55.29	-0.76	-1.71
Price/Sales	-55.29	10.30	23.04
Price/FCF	55.29	-6.72	-15.02
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.88	0.88
Operating Margin	0.00	-1.75	-1.75
ROA	-100.00	-0.35	0.00
ROE	0.00	-0.83	-100.00
ROIC	0.00	-0.19	-100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.57	0.00	inf
EPS QOQ	-2.16	0.00	inf
FCF QOQ	-0.80	0.00	inf
Revenue QOQ	-0.51	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	n.A.	310.65	n.A.
Days Sales Outstanding (DSO)	n.A.	51.10	n.A.
Inventory Turnover	0.00	0.29	100.00
Debt/Capitalization	0.00	0.49	100.00
Quick Ratio	0.00	0.84	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	n.A.	0.25	n.A.
Cash	n.A.	0.06	n.A.
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	-0.09	-0.09	0.00
Revenue	0.06	0.06	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	1.05	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	-1.62	n.A.
Naive Interpretation	Member

06 - Financial Health · Bad

Rating